Drugs / Restorative Microbiota Therapy
last change Nov 2022 re-read 2 minutes ago

Restorative Microbiota Therapy

Developed for
lung adenocarcinoma
Investigated by
Masonic Cancer Center, University of Minnesota

Trials 1 · a red edge is where a trial was stopped

202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04105270 Nov 2022 → Jan 2028 expected lung adenocarcinoma Masonic Cancer Center, University of Minnesota Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Restorative Microbiota Therapy ClinicalTrials.gov intervention name — accepted as the source's own label NCT04105270
Route Oral oral restorative microbiota therapy (RMT) or placebo” NCT04105270